Mid Cap SPDR 400 Trust, Series 1 (MDY)

Commvault Systems has seen a 22.49% stock-price rise since January 30th, with investors increasingly bullish on the data-recovery specialist's prospects.

Wendy's stock climbed after the company backed away from surge pricing after social media backlash. Revenue is slowing, but Wall Street sees upside.

It's rare for a company like Nvidia to achieve 200% earnings growth. Smaller stocks Fluor, Jefferies and Golden Entertainment also show explosive EPS growth.

Chesapeake and Southwestern's $7.4 billion merger aims to address the growing global demand for natural gas; the companies expect a 20% dividend increase

Celsius gained momentum in the last trading days of 2023 after a November pullback. Celsius' growth is fueled by strong revenue and support from backer PepsiCo.

Super Micro Computer's latest earnings report highlights its strength in AI infrastructure. The company anticipates strong growth in fiscal year 2024

Network gear maker Ciena saw a sizeable gap-up in stock price after strong Q3 earnings. What does that say about prospects for the broader industry?

Kinsale Capital Group beat Wall Street views, spurring price outperformance relative to other insurers and its mid-cap index. Institutions are buying shares.

Emcor Group shows strong buying support as it bounces off its 50-day average. The stock is outperforming its index as earnings growth accelerates.

Shockwave earnings are growing at triple-digit rates. The company easily beat Q1 views. Boston Scientific is reportedly interested in acquiring Shockwave.

Mid-cap industrial-sector stock Donaldson is a steady gainer, returning 32.44% in the past year. It has a 36-year track record of increasing its dividend.

Texas Roadhouse found support at its 50-day average after missing Q1 earnings views. The company reiterated expectations for sales growth this year.

Hubbell stock is trading at new highs following better-than-expected Q1 results. Wall Street sees the company growing earnings by 27% this year.

Chemical maker Cabot is growing to meet demand for materials to produce lithium-ion batteries. It may offer a buy opportunity on a moving-average pullback.

Neurocrine Biosciences trended higher with the broad market Thursday, coming within a penny of Tuesday’s high of $125.99. It is forming a bullish channel.

Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test.

Digi International, Lamb Weston Holdings, and Wingstop traded higher in heavy trading volume,. Mid-caps are outperforming the S&P 500 large-cap index this year.